Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Market Insights | Asia Pacific | 2021

The COVID-19 global pandemic will have a significant impact on the Asia Pacific heart valve device market, resulting in lost procedure volumes in the short term followed by a period of recovery. However, once circumstances improve, the Asia Pacific heart valve device market will experience robust growth through 2029, driven by economic expansion, an aging population, and the launch and adoption of new THV devices. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in Asia Pacific across a 10-year period.

Related Medtech Insights Reports

Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…
Report
Trauma Devices – Market Insights – Asia Pacific
The Asia Pacific trauma device market is experiencing steady growth driven by a rising incidence of fractures, an aging population, and increasing rates of road traffic accidents, particularly in…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Asia Pacific
The Asia Pacific TEO device market will experience steady growth over the forecast period, driven by rising cancer incidence, increasing preference for minimally invasive procedures, and clinical…